Think Research Corporation
XTSX:THNK
Think Research Corporation
Cash from Financing Activities
Think Research Corporation
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
T
|
Think Research Corporation
XTSX:THNK
|
Cash from Financing Activities
CA$6.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Biotricity Inc
NASDAQ:BTCY
|
Cash from Financing Activities
$7m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
C
|
CardioComm Solutions Inc
XTSX:EKG
|
Cash from Financing Activities
CA$109.9k
|
CAGR 3-Years
535%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-21%
|
Avricore Health Inc
XTSX:AVCR
|
Cash from Financing Activities
CA$257.4k
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
-10%
|
|
Diagnos Inc
XTSX:ADK
|
Cash from Financing Activities
CA$1.7m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
N
|
NetraMark Holdings Inc
CNSX:AIAI
|
Cash from Financing Activities
CA$4.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Think Research Corporation's Cash from Financing Activities?
Cash from Financing Activities
6.4m
CAD
Based on the financial report for Dec 31, 2022, Think Research Corporation's Cash from Financing Activities amounts to 6.4m CAD.
What is Think Research Corporation's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
-81%
Over the last year, the Cash from Financing Activities growth was -81%.